Aspiro Pharma Limited recalls Ketorolac Tromethamine Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Presence of Particulate Matter: Particulate matter identified as glass
- Products
-
- Ketorolac Tromethamine Injection
- Company
- Aspiro Pharma Limited
- Where it was sold
-
Nationwide within the United States
Nationwide
- About this recall
- Ketorolac Tromethamine Injection, USP, 60 mg/2 mL (30 mg/mL), 2 mL Single-Dose Vial, For Intramuscular Use Only, Rx only, Mfd. for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Mfd. by: ASPIRO PHARMA LIMITED, Telangana - 502281, INDIA., U.S. Contact Number: 1-866-495-1995, NDC 31722-307-25 (Carton), 31722-307-02 (Vial label).